Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs HSP Gp96 vaccine (Primary)
- Indications Liver cancer; Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Cure&Sure Biotech
- 10 Jun 2017 Biomarkers information updated
- 10 Dec 2015 Planned End Date changed from 1 Jul 2016 to 1 Nov 2019 as reported by ClinicalTrials.gov record.
- 10 Dec 2015 Planned primary completion date changed from 1 Jul 2014 to 1 Nov 2016 as reported by ClinicalTrials.gov record.